Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

September 1, 1985; Volume 135,Issue 3
  • You have accessRestricted access
    Commentary on the genetic basis for control of I-J determinants.
    D B Murphy
    J Immunol September 1, 1985, 135 (3) 1543-1547;
  • You have accessRestricted access
    Conditions required for expression of membrane IL 1 on B cells.
    E A Kurt-Jones, J M Kiely and E R Unanue
    J Immunol September 1, 1985, 135 (3) 1548-1550;
  • You have accessRestricted access
    5-Azacytidine treatment of a murine cytotoxic T cell line alters interferon-gamma gene induction by interleukin 2.
    W L Farrar, F W Ruscetti and H A Young
    J Immunol September 1, 1985, 135 (3) 1551-1554;
  • You have accessRestricted access
    Variable requirement for murine lymphocyte function-associated antigen-1 (LFA-1) in T cell-mediated lysis depending upon the tissue origin of the target cells.
    R Shimonkevitz, J C Cerottini and H R MacDonald
    J Immunol September 1, 1985, 135 (3) 1555-1557;
  • You have accessRestricted access
    TNP-specific Lyt-2+ cytolytic T cell clones preferentially respond to TNP-conjugated epidermal cells.
    S Shimada and S I Katz
    J Immunol September 1, 1985, 135 (3) 1558-1563;
  • You have accessRestricted access
    Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
    K Handa and S Herrmann
    J Immunol September 1, 1985, 135 (3) 1564-1572;
  • You have accessRestricted access
    T cell regulation of light chain expression: preferential enhancement of Ig kappa in a primary thymus-dependent response does not require affinity-based selection.
    L C Burkly, J Nikolic and H H Wortis
    J Immunol September 1, 1985, 135 (3) 1573-1576;
  • You have accessRestricted access
    T cell regulation of light chain expression: preferential enhancement of Ig kappa production by T cells in the response to DNP.
    L C Burkly and H H Wortis
    J Immunol September 1, 1985, 135 (3) 1577-1581;
  • You have accessRestricted access
    Isolation and characterization of novel suppressor T cell clones from murine fetal thymus.
    H S Teh, M Ho and W R McMaster
    J Immunol September 1, 1985, 135 (3) 1582-1588;
  • You have accessRestricted access
    Genetic and biological characterization of a T suppressor cell induced by anti-idiotypic antibody.
    J G Monroe, M Gurish, J Dambrauskas, M Slaoui, A Lowy and M I Greene
    J Immunol September 1, 1985, 135 (3) 1589-1597;
  • You have accessRestricted access
    In vivo helper activity of autoreactive T cell clones.
    K Tomonari
    J Immunol September 1, 1985, 135 (3) 1598-1602;
  • You have accessRestricted access
    Analysis of a TH1----TH2 helper cell circuit.
    M McNamara, C Y Kang and H Kohler
    J Immunol September 1, 1985, 135 (3) 1603-1609;
  • You have accessRestricted access
    Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.
    H Golding and A Singer
    J Immunol September 1, 1985, 135 (3) 1610-1615;
  • You have accessRestricted access
    Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    B Bonavida and J Katz
    J Immunol September 1, 1985, 135 (3) 1616-1623;
  • You have accessRestricted access
    T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
    P Brottier, L Boumsell, C Gelin and A Bernard
    J Immunol September 1, 1985, 135 (3) 1624-1631;
  • You have accessRestricted access
    The distribution of the Qa-2 alloantigen on functional T lymphocytes.
    P M Hogarth, A Basten, H Prichard-Briscoe, M H Henning, V R Sutton and I F McKenzie
    J Immunol September 1, 1985, 135 (3) 1632-1636;
  • You have accessRestricted access
    GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
    P F Piguet
    J Immunol September 1, 1985, 135 (3) 1637-1643;
  • You have accessRestricted access
    Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    T Maier, J H Holda and H N Claman
    J Immunol September 1, 1985, 135 (3) 1644-1651;
  • You have accessRestricted access
    Strong suppression by monocytes of T cell mitogenesis in chicken peripheral blood leukocytes.
    A E Schaefer, A R Scafuri, T L Fredericksen and D G Gilmour
    J Immunol September 1, 1985, 135 (3) 1652-1660;
  • You have accessRestricted access
    Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
    A K Abbas, S Haber and K L Rock
    J Immunol September 1, 1985, 135 (3) 1661-1667;
  • You have accessRestricted access
    Molecular associations of class II MHC antigens in mitogen-stimulated B cells.
    R L Wolfert, M G Goodman and W O Weigle
    J Immunol September 1, 1985, 135 (3) 1668-1673;
  • You have accessRestricted access
    Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.
    J G Monroe and M J Kass
    J Immunol September 1, 1985, 135 (3) 1674-1682;
  • You have accessRestricted access
    Failure of PFC inhibition assays to distinguish idiotypically between clonotypes that are readily distinguishable by RIA analysis.
    B S Schepart, G L Mayers and R B Bankert
    J Immunol September 1, 1985, 135 (3) 1683-1689;
  • You have accessRestricted access
    Antibody response of BALB/c mice to dextran B1355S: alterations in the expression of an idiotype associated with the depletion of idiotype-binding cells.
    B S Schepart, M Abu-Hadid, G L Mayers and R B Bankert
    J Immunol September 1, 1985, 135 (3) 1690-1697;
  • You have accessRestricted access
    Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
    D Wofsy, D C Mayes, J Woodcock and W E Seaman
    J Immunol September 1, 1985, 135 (3) 1698-1701;
  • You have accessRestricted access
    Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
    V J Merluzzi, D M Savage, M D Smith, K Last-Barney, R Mertelsmann, M A Moore and K Welte
    J Immunol September 1, 1985, 135 (3) 1702-1706;
  • You have accessRestricted access
    Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract.
    R A Eisenberg
    J Immunol September 1, 1985, 135 (3) 1707-1713;
  • You have accessRestricted access
    Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    R Schwab, M K Crow, C Russo and M E Weksler
    J Immunol September 1, 1985, 135 (3) 1714-1718;
  • You have accessRestricted access
    Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    C D Tsoukas, B Landgraf, J Bentin, M Valentine, M Lotz, J H Vaughan and D A Carson
    J Immunol September 1, 1985, 135 (3) 1719-1723;
  • You have accessRestricted access
    Antigen-specific suppressor T lymphocytes in man make use of the same set of surface molecules as do cytolytic T lymphocytes: roles of Leu-2/T8, Leu-4/T3, Leu-5/T11, LFA-1 molecules.
    N K Damle, D M Fishwild and E G Engleman
    J Immunol September 1, 1985, 135 (3) 1724-1730;
  • You have accessRestricted access
    Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
    P G Hogan, A J Hapel and W F Doe
    J Immunol September 1, 1985, 135 (3) 1731-1738;
  • You have accessRestricted access
    Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens.
    I H Frazer, I R Mackay, T W Jordan, S Whittingham and S Marzuki
    J Immunol September 1, 1985, 135 (3) 1739-1745;
  • You have accessRestricted access
    Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells.
    P Hokland, J Ritz, S F Schlossman and L M Nadler
    J Immunol September 1, 1985, 135 (3) 1746-1751;
  • You have accessRestricted access
    Human T cell antigen expression during the early stages of fetal thymic maturation.
    D F Lobach, L L Hensley, W Ho and B F Haynes
    J Immunol September 1, 1985, 135 (3) 1752-1759;
  • You have accessRestricted access
    Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.
    R P Hall and T J Lawley
    J Immunol September 1, 1985, 135 (3) 1760-1765;
  • You have accessRestricted access
    Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
    V M Lem, M F Lipscomb, J C Weissler, G Nunez, E J Ball, P Stastny and G B Toews
    J Immunol September 1, 1985, 135 (3) 1766-1771;
  • You have accessRestricted access
    Immune response to nucleic acid antigens and native DNA by human peripheral blood lymphocytes in vitro.
    D Bastian, H Borel, T Sasaki, A D Steinberg and Y Borel
    J Immunol September 1, 1985, 135 (3) 1772-1777;
  • You have accessRestricted access
    Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    J F Salazar-Gonzalez, D J Moody, J V Giorgi, O Martinez-Maza, R T Mitsuyasu and J L Fahey
    J Immunol September 1, 1985, 135 (3) 1778-1785;
  • You have accessRestricted access
    Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
    T F Tedder, M J Crain, H Kubagawa, L T Clement and M D Cooper
    J Immunol September 1, 1985, 135 (3) 1786-1791;
  • You have accessRestricted access
    Preferential generation of human T cell hybrids with a tetraploid fusion partner.
    A E Berger, S L Kuentzel and S O Davidson
    J Immunol September 1, 1985, 135 (3) 1792-1799;
  • You have accessRestricted access
    Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity.
    L C Uhteg, D R Salomon, L L Rocher, J W Kupiec-Weglinski, J L Araujo, M F Rubin, N L Tilney and C B Carpenter
    J Immunol September 1, 1985, 135 (3) 1800-1805;
  • You have accessRestricted access
    Longitudinal assessment of immunologic abnormalities of mice with the autosomal recessive mutation, "wasted".
    D Goldowitz, P M Shipman, J F Porter and R R Schmidt
    J Immunol September 1, 1985, 135 (3) 1806-1812;
  • You have accessRestricted access
    Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
    N Oudrhiri, J P Farcet, M F Gourdin, M Divine, J Bouguet, D Fradelizi and F Reyes
    J Immunol September 1, 1985, 135 (3) 1813-1818;
  • You have accessRestricted access
    Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.
    J A Ledbetter, L M Rose, C E Spooner, P G Beatty, P J Martin and E A Clark
    J Immunol September 1, 1985, 135 (3) 1819-1825;
  • You have accessRestricted access
    Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
    T R Malek, C Chan, L H Glimcher, R N Germain and E M Shevach
    J Immunol September 1, 1985, 135 (3) 1826-1833;
  • You have accessRestricted access
    Characterization and partial purification of a specific interleukin 2 inhibitor.
    M Honda, C Chan and E M Shevach
    J Immunol September 1, 1985, 135 (3) 1834-1839;
  • You have accessRestricted access
    Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
    D Katzen, E Chu, C Terhost, D Y Leung, M Gesner, R A Miller and R S Geha
    J Immunol September 1, 1985, 135 (3) 1840-1845;
  • You have accessRestricted access
    Interleukin 2 receptor dysfunction in mice undergoing a graft-vs-host reaction.
    L J Joseph, T Iwasaki, T R Malek and G M Shearer
    J Immunol September 1, 1985, 135 (3) 1846-1850;
  • You have accessRestricted access
    Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
    J Vilcek, D Henriksen-Destefano, D Siegel, A Klion, R J Robb and J Le
    J Immunol September 1, 1985, 135 (3) 1851-1856;
  • You have accessRestricted access
    Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.
    P D Ling, M K Warren and S N Vogel
    J Immunol September 1, 1985, 135 (3) 1857-1863;
  • You have accessRestricted access
    Interleukins 2 and 3 regulate the in vitro proliferation of two distinguishable populations of 20-alpha-hydroxysteroid dehydrogenase-positive cells.
    J R Keller, Y Weinstein, M Hursey and J N Ihle
    J Immunol September 1, 1985, 135 (3) 1864-1871;
  • You have accessRestricted access
    Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.
    C R Albrightson, N L Baenziger and P Needleman
    J Immunol September 1, 1985, 135 (3) 1872-1877;
  • You have accessRestricted access
    Differential requirements for the production by a T helper clone of the lymphokines involved in the induction of polyclonal proliferation and differentiation of unstimulated B lymphocytes.
    M L Gougeon, L Leclercq, G Bismuth and J Thèze
    J Immunol September 1, 1985, 135 (3) 1878-1883;
  • You have accessRestricted access
    Clonal analysis of B cell growth and differentiation activities induced from T lymphocytes upon triggering of T3-Ti and T11 pathways.
    C Milanese, A Bensussan and E L Reinherz
    J Immunol September 1, 1985, 135 (3) 1884-1890;
  • You have accessRestricted access
    Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
    H Jyonouchi, M D Kimmel, G Lee, P W Kincade and R A Good
    J Immunol September 1, 1985, 135 (3) 1891-1899;
  • You have accessRestricted access
    Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
    W G Bessler, M Cox, A Lex, B Suhr, K H Wiesmüller and G Jung
    J Immunol September 1, 1985, 135 (3) 1900-1905;
  • You have accessRestricted access
    Lipopolysaccharide receptors on lymphocytes. I. Lack of immunologic recognition of a putative LPS receptor on LPS-responder lymphocytes by LPS-nonresponder mice.
    S A Goodman and D C Morrison
    J Immunol September 1, 1985, 135 (3) 1906-1910;
  • You have accessRestricted access
    Carbohydrate determinants associated with carcinoembryonic antigen (CEA).
    E J Nichols, R Kannagi, S I Hakomori, M J Krantz and A Fuks
    J Immunol September 1, 1985, 135 (3) 1911-1913;
  • You have accessRestricted access
    Analysis of idiotope variability as a function of distance from the binding site for anti-streptococcal group A carbohydrate antibodies.
    N S Greenspan and J M Davie
    J Immunol September 1, 1985, 135 (3) 1914-1921;
  • You have accessRestricted access
    Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.
    H Spits, J Borst, W Tax, P J Capel, C Terhorst and J E de Vries
    J Immunol September 1, 1985, 135 (3) 1922-1928;
  • You have accessRestricted access
    Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
    C R Maliszewski, E D Ball, R F Graziano and M W Fanger
    J Immunol September 1, 1985, 135 (3) 1929-1936;
  • You have accessRestricted access
    Biosynthesis and maturation of the Lyt-2/3 molecular complex in mouse thymocytes.
    B Lüscher, M Rousseaux-Schmid, H Y Naim, H R MacDonald and C Bron
    J Immunol September 1, 1985, 135 (3) 1937-1944;
  • You have accessRestricted access
    The structure-function relationship of I-A molecules: a biochemical analysis of I-A polypeptides from mutant antigen-presenting cells and evidence of preferential association of allelic forms.
    G G Schlauder, M P Bell, B N Beck, A Nilson and D J McKean
    J Immunol September 1, 1985, 135 (3) 1945-1954;
  • You have accessRestricted access
    Structural similarities in the kappa light chains of human rheumatoid factor paraproteins and serum immunoglobulins bearing a cross-reactive idiotype.
    S Fong, P P Chen, T A Gilbertson, R I Fox, J H Vaughan and D A Carson
    J Immunol September 1, 1985, 135 (3) 1955-1960;
  • You have accessRestricted access
    A reevaluation of rabbit anti-allotype antibody for the presence of cross-reactive idiotypes. I. A species-specific idiotype on rabbit anti-a1 antibody is recognized by guinea pig anti-IdX antibody.
    K H Roux, W T McCormack and P Dhanarajan
    J Immunol September 1, 1985, 135 (3) 1961-1966;
  • You have accessRestricted access
    A reevaluation of rabbit anti-allotype antibody for the presence of cross-reactive idiotypes. II. Expression of rabbit a1-like images on goat antibody after immunization with anti-a1 antibody.
    K H Roux, W T McCormack and P Dhanarajan
    J Immunol September 1, 1985, 135 (3) 1967-1974;
  • You have accessRestricted access
    Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
    D McCool, B K Birshtein and R H Painter
    J Immunol September 1, 1985, 135 (3) 1975-1980;
  • You have accessRestricted access
    Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions.
    S S Sung
    J Immunol September 1, 1985, 135 (3) 1981-1986;
  • You have accessRestricted access
    Antiproliferative monoclonal antibodies: detection and initial characterization.
    L Vaickus and R Levy
    J Immunol September 1, 1985, 135 (3) 1987-1997;
  • You have accessRestricted access
    A third immunoglobulin class in amphibians.
    E Hsu, M F Flajnik and L Du Pasquier
    J Immunol September 1, 1985, 135 (3) 1998-2004;
  • You have accessRestricted access
    Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    G D Ross, W J Yount, M J Walport, J B Winfield, C J Parker, C R Fuller, R P Taylor, B L Myones and P J Lachmann
    J Immunol September 1, 1985, 135 (3) 2005-2014;
  • You have accessRestricted access
    Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
    J D Tamerius, M K Pangburn and H J Müller-Eberhard
    J Immunol September 1, 1985, 135 (3) 2015-2019;
  • You have accessRestricted access
    The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: effects of secretagogues and anti-allergic drugs on histamine secretion.
    K E Barrett and D D Metcalfe
    J Immunol September 1, 1985, 135 (3) 2020-2026;
  • You have accessRestricted access
    A histamine-releasing factor from activated human mononuclear cells.
    A P Kaplan, M Haak-Frendscho, A Fauci, C Dinarello and E Halbert
    J Immunol September 1, 1985, 135 (3) 2027-2032;
  • You have accessRestricted access
    Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
    R E Rocklin, L Thistle and C Audera
    J Immunol September 1, 1985, 135 (3) 2033-2039;
  • You have accessRestricted access
    Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.
    R M Schultz, S K Nanda and M G Altom
    J Immunol September 1, 1985, 135 (3) 2040-2044;
  • You have accessRestricted access
    Immune oxidative injury induced in mice exposed to normobaric O2: effects of thiol compounds on the splenic cell sulfhydryl content and Con A proliferative response.
    M A Gougerot-Pocidalo, M Fay, Y Roche, P Lacombe and C Marquetty
    J Immunol September 1, 1985, 135 (3) 2045-2051;
  • You have accessRestricted access
    Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products.
    E J Wing, N M Ampel, A Waheed and R K Shadduck
    J Immunol September 1, 1985, 135 (3) 2052-2056;
  • You have accessRestricted access
    Phorbol myristate acetate mediates redistribution of protein kinase C in human neutrophils: potential role in the activation of the respiratory burst enzyme.
    M Wolfson, L C McPhail, V N Nasrallah and R Snyderman
    J Immunol September 1, 1985, 135 (3) 2057-2062;
  • You have accessRestricted access
    Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
    R Huey and T E Hugli
    J Immunol September 1, 1985, 135 (3) 2063-2068;
  • You have accessRestricted access
    Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
    M R Shalaby, B B Aggarwal, E Rinderknecht, L P Svedersky, B S Finkle and M A Palladino Jr
    J Immunol September 1, 1985, 135 (3) 2069-2073;
  • You have accessRestricted access
    Mechanism of priming of human neutrophils by a soluble lymphoblastoid cell factor.
    A S Cross, G H Lowell, J Palmblad, J C Sadoff, L Young and M Berger
    J Immunol September 1, 1985, 135 (3) 2074-2083;
  • You have accessRestricted access
    cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells.
    K M Gilbert and M K Hoffmann
    J Immunol September 1, 1985, 135 (3) 2084-2089;
  • You have accessRestricted access
    Functional integrity of cytokineplasts: specific chemotactic and capping responses.
    D E Dyett, S E Malawista, G Van Blaricom, D A Melnick and H L Malech
    J Immunol September 1, 1985, 135 (3) 2090-2094;
  • You have accessRestricted access
    Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
    F Y Liew, C Hale and J G Howard
    J Immunol September 1, 1985, 135 (3) 2095-2101;
  • You have accessRestricted access
    Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    F Y Liew, A Singleton, E Cillari and J G Howard
    J Immunol September 1, 1985, 135 (3) 2102-2107;
  • You have accessRestricted access
    Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    R G Titus, R Ceredig, J C Cerottini and J A Louis
    J Immunol September 1, 1985, 135 (3) 2108-2114;
  • You have accessRestricted access
    Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites.
    D A Harn, M Mitsuyama, E D Huguenel and J R David
    J Immunol September 1, 1985, 135 (3) 2115-2120;
  • You have accessRestricted access
    Immune responses during human Schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment.
    G Gazzinelli, J R Lambertucci, N Katz, R S Rocha, M S Lima and D G Colley
    J Immunol September 1, 1985, 135 (3) 2121-2127;
  • You have accessRestricted access
    Induction of antibody responses to influenza virus in human lymphocyte cultures. I. Role of interleukin 2.
    P L Tan, R J Booth, R L Prestidge, J D Watson, S K Dower and S Gillis
    J Immunol September 1, 1985, 135 (3) 2128-2133;
  • You have accessRestricted access
    Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells.
    J L Hurwitz and C J Hackett
    J Immunol September 1, 1985, 135 (3) 2134-2139;
  • You have accessRestricted access
    Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells.
    I Kurane, L N Binn, W H Bancroft and F A Ennis
    J Immunol September 1, 1985, 135 (3) 2140-2144;
  • You have accessRestricted access
    Demyelination induced by Theiler's virus: influence of the H-2 haplotype.
    M Rodriguez and C S David
    J Immunol September 1, 1985, 135 (3) 2145-2148;
  • You have accessRestricted access
    HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant.
    J Böhme, M Andersson, G Andersson, E Möller, P A Peterson and L Rask
    J Immunol September 1, 1985, 135 (3) 2149-2155;
  • You have accessRestricted access
    Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha.
    H Inoko, A Ando, M Kimura and K Tsuji
    J Immunol September 1, 1985, 135 (3) 2156-2159;
  • You have accessRestricted access
    Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    I Stroynowski, S Clark, L A Henderson, L Hood, M McMillan and J Forman
    J Immunol September 1, 1985, 135 (3) 2160-2166;
  • You have accessRestricted access
    Structure and expression of two porcine genomic clones encoding class I MHC antigens.
    M L Satz, L C Wang, D S Singer and S Rudikoff
    J Immunol September 1, 1985, 135 (3) 2167-2175;
  • You have accessRestricted access
    The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype.
    N W Roehm, A Carbone, E Kushnir, B A Taylor, R J Riblet, P Marrack and J W Kappler
    J Immunol September 1, 1985, 135 (3) 2176-2182;
  • You have accessRestricted access
    Influence of antibody isotype on passive serotherapy of lymphoma.
    E Y Denkers, C C Badger, J A Ledbetter and I D Bernstein
    J Immunol September 1, 1985, 135 (3) 2183-2186;
  • You have accessRestricted access
    The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.
    H Fujiwara, Y Takai, K Sakamoto and T Hamaoka
    J Immunol September 1, 1985, 135 (3) 2187-2191;
  • You have accessRestricted access
    Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    S K Chapes and L R Gooding
    J Immunol September 1, 1985, 135 (3) 2192-2198;
  • You have accessRestricted access
    Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    H Nakajima, H Fujiwara, Y Takai, Y Izumi, S Sano, T Tsuchida and T Hamaoka
    J Immunol September 1, 1985, 135 (3) 2199-2205;
  • You have accessRestricted access
    Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
    A S Edelman, B Xue, P Sanchez and G J Thorbecke
    J Immunol September 1, 1985, 135 (3) 2206-2212;
  • You have accessRestricted access
    Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence.
    A S Edelman, B Xue, J E Galton, P Sanchez and G J Thorbecke
    J Immunol September 1, 1985, 135 (3) 2213-2219;
  • You have accessRestricted access
    T cell locomotion in the tumor microenvironment. I. A collagen-matrix assay.
    S Ratner and G H Heppner
    J Immunol September 1, 1985, 135 (3) 2220-2227;

ERRATA

  • You have accessRestricted access
    Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production
    D Frasca, L Adorini, S Landolfo and G Doria
    J Immunol September 1, 1985, 135 (3) 2228;
  • You have accessRestricted access
    Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line
    CY Lau, EY Wang, D Li, S Budz-Tymkewycz, V Visconti and A Ishaque
    J Immunol September 1, 1985, 135 (3) 2228;
  • You have accessRestricted access
    Tolerance to azobenzenearsonate: idiotype-specific suppression, B cell dominance, and clonal elimination
    ET Collins, ED Hershey and DC Benjamin
    J Immunol September 1, 1985, 135 (3) 2228;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 135, Issue 3
1 Sep 1985
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ERRATA
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606